Title |
Symptoms and markers of symptom severity in asthma—content validity of the asthma symptom diary
|
---|---|
Published in |
Health and Quality of Life Outcomes, January 2015
|
DOI | 10.1186/s12955-015-0217-5 |
Pubmed ID | |
Authors |
Gary Globe, Mona Martin, Michael Schatz, Ingela Wiklund, Joseph Lin, Robyn von Maltzahn, Maria S Mattera |
Abstract |
The American Thoracic Society/European Respiratory Society (ATS/ERS) Task Force acknowledged the multi-faceted nature of asthma in its recent definition of asthma control as a summary term capturing symptoms, reliever use, frequency/severity of exacerbations, lung function, and future risk and the Global Initiative for Asthma (GINA) defines the clinical manifestations (well established markers of asthma severity) of asthma to include symptoms, sleep disturbances, limitations of daily activity, impairment of lung function, and use of rescue medications. The objectives of this qualitative work were to identify symptoms and markers of symptom severity relevant to patients with moderate to severe asthma and to evaluate the content validity of the asthma symptom diary (ASD). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 1 | <1% |
Unknown | 160 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 32 | 20% |
Student > Master | 19 | 12% |
Student > Ph. D. Student | 18 | 11% |
Student > Doctoral Student | 11 | 7% |
Researcher | 9 | 6% |
Other | 21 | 13% |
Unknown | 51 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 24% |
Nursing and Health Professions | 19 | 12% |
Biochemistry, Genetics and Molecular Biology | 8 | 5% |
Psychology | 7 | 4% |
Agricultural and Biological Sciences | 4 | 2% |
Other | 26 | 16% |
Unknown | 59 | 37% |